RPRX — Royalty Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual balance sheet for Royalty Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,803	2,428	1,234	1,771	1,492
Net Total Accounts Receivable
Net Total Receivables	68.3	36.6	36.6	27	29.3
Total Other Current Assets
Total Current Assets	2,878	2,555	1,274	1,802	1,528
Net Property, Plant And Equipment	—	—	—	—	19.1
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	17,516	16,813	16,382	18,223	19,621
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	171	1,167	161	1,254	636
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	11,739	11,185	9,855	11,276	13,144
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	5,777	5,628	6,526	6,947	6,477
Total Liabilities & Shareholders' Equity	17,516	16,813	16,382	18,223	19,621
Total Common Shares Outstanding